Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 10:07 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2713–2736 of 2,764 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: High Activity Clear all

Conditions: Spastic Cerebral Palsy
Interventions: Selective movement of individual lower limb joints, Knee joint strengthening at high velocities, Ankle controlled gaming, Functional activities based on child and parental goals, Sensori-motor exercises; Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 5 Years to 18 Years
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Heart Failure With Preserved Ejection Fraction (HFpEF)
Interventions: Verinurad, Allopurinol, Placebo for verinurad, Placebo for allopurinol; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 40 Years to 130 Years
Enrollment: 159 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 8
States / cities: Granada Hills, California • Northridge, California • Torrance, California + 5 more

Conditions: Chronic Pain
Interventions: Cognitive Behavioral Therapy, Chronic Pain Self Management Program, Taper Only; Behavioral · Other
Lead sponsor: Stanford University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 1,462 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Lower Back Injury
Interventions: Lumbar ext. high intensity progressive resistance exercise, Low intensity core stabilization exercise; Other
Lead sponsor: University of South Florida; Other
Eligibility: 18 Years to 35 Years
Enrollment: 582 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 2
States / cities: Tampa, Florida • Fort Sam Houston, Texas

Conditions: Low Back Pain
Interventions: Medical Care, Dual Care, Shared Care; Other
Lead sponsor: Palmer College of Chiropractic; Other
Eligibility: 65 Years and older
Enrollment: 131 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 2
States / cities: Davenport, Iowa

Conditions: Alzheimer Disease, Dementia, Dementia, Vascular, Dementia, Mixed
Interventions: SAFE at Home; Behavioral
Lead sponsor: Hopeful Aging; Industry
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024
U.S. locations: 1
States / cities: Winchester, Massachusetts

Conditions: Postmenopausal Female Patients, Vasomotor Symptoms, Menopausal Hormone Therapy
Interventions: Moderate Intensity Exercise (MIE), High intensity exercise (HIE), Control (No exercise); Other
Lead sponsor: University of Virginia; Other
Eligibility: 45 Years to 75 Years · Female only
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Norovirus Infections
Interventions: VXA-GI.1.NN, Placebo Tablet; Biological
Lead sponsor: Vaxart; Industry
Eligibility: 55 Years to 80 Years
Enrollment: 66 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2022
U.S. locations: 3
States / cities: Cypress, California • New Orleans, Louisiana • Austin, Texas

Conditions: Fragile X Syndrome
Interventions: Low dose of MRM-3379, Middle Dose of MRM-3379, High dose of MRM-3379, Placebo, Low dose of MRM-3379 Open-Label; Drug
Lead sponsor: Mirum Pharmaceuticals, Inc.; Industry
Eligibility: 13 Years to 45 Years · Male only
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 15
States / cities: Phoenix, Arizona • Irvine, California • Orange, California + 12 more

Conditions: Fatigue, Depression, Pain, Sleep Disturbance, Stress, Survivorship, Breast Cancer, Dietary Habits
Interventions: Personalized Meal Plan, Dietary Omega-3LC intervention; Behavioral
Lead sponsor: University of Connecticut; Other
Eligibility: 35 Years to 70 Years · Female only
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Hartford, Connecticut

Conditions: Executive Dysfunction, Autism Spectrum Disorder, Adolescent Behavior
Interventions: Unstuck & On Target: High School, Treatment as Usual; Behavioral · Other
Lead sponsor: Children's National Research Institute; Other
Eligibility: 14 Years to 22 Years
Enrollment: 178 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Rockville, Maryland

Conditions: Osteoarthritis, Knee
Interventions: XT-150, Placebo; Biological · Drug
Lead sponsor: Xalud Therapeutics, Inc.; Industry
Eligibility: 45 Years to 85 Years
Enrollment: 289 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 4
States / cities: La Mesa, California • Napa, California • Santa Monica, California + 1 more

Conditions: Chronic Kidney Disease and Hypertension
Interventions: Baxdrostat/dapagliflozin, Dapagliflozin in combination with placebo; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: 18 Years and older
Enrollment: 2,554 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 114
States / cities: Fairhope, Alabama • Phoenix, Arizona • Surprise, Arizona + 97 more

Conditions: HIV Infections
Interventions: Pneumococcal 7-valent conjugate vaccine, Pneumococcal polysaccharide vaccine, Hepatitis B vaccine, Measles, mumps, and rubella virus vaccine, live; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 6 Years to 23 Years
Enrollment: 101 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006
U.S. locations: 24
States / cities: Birmingham, Alabama • Alhambra, California • Long Beach, California + 17 more

Conditions: Traumatic Brain Injury, Gait Disorders, Neurologic
Interventions: HIGT - physical rehab, Low intensity physical therapy; Other
Lead sponsor: Carilion Clinic; Other
Eligibility: 18 Years to 65 Years
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Roanoke, Virginia

Conditions: Aging, Generativity
Interventions: Experience Corps; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 60 Years and older
Enrollment: 702 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Stress, Psychological, Stress, Emotional, Stress, Physiological
Interventions: Ethnic and Racial Identity Promotion, Academic Skills Promotion; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 13 Years to 18 Years
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2032
U.S. locations: 3
States / cities: Evanston, Illinois • Niles, Illinois

Conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Interventions: RSVpreF 120 µg, RSVpreF 60 µg; Biological
Lead sponsor: Pfizer; Industry
Eligibility: 2 Years to 17 Years
Enrollment: 128 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 17
States / cities: Birmingham, Alabama • Palo Alto, California • Rolling Hills Estates, California + 12 more

Conditions: Hypertension
Interventions: Artificial Intelligence (AI) Activity, 10,000 steps; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Multiple Sclerosis (MS) - Relapsing-remitting, Multiple Sclerosis (MS) Secondary Progressive, Multiple Sclerosis (MS) Primary Progressive
Interventions: Remibrutinib (Open Label); Drug
Lead sponsor: Moein Amin; Other
Eligibility: 18 Years to 60 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Hypertension
Interventions: Clonidine, Nitroglycerin transdermal, Dipyridamole/ Aspirin (Aggrenox), Desmopressin (DDAVP), Sildenafil, Nifedipine, Hydralazine, Hydrochlorothiazide, Placebo, Bosentan, Diltiazem, Eplerenone, guanfacine, L-arginine, captopril, carbidopa, losartan, metoprolol tartrate, nebivolol hydrochloride, prazosin hydrochloride, tamsulosin hydrochloride, Head-up tilt., aliskiren, Local heat stress; Drug · Dietary Supplement · Other
Lead sponsor: Vanderbilt University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 152 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2001 – 2017
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Cancer, Metastatic Castration-resistant Prostate Cancer, mCRPC
Interventions: INKmune; Biological
Lead sponsor: Inmune Bio, Inc.; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 8
States / cities: Los Angeles, California • Las Vegas, Nevada • Cincinnati, Ohio + 4 more

Conditions: IgA Nephropathy (IgAN)
Interventions: Avacopan, Prednisone, Methylprednisolone (drug), Prednisolone; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 2
States / cities: Jacksonville, Florida • Rochester, Minnesota

Conditions: Frailty, Functional Recovery, Prehabilitation
Interventions: Exercise, Nutrition, Meditation, Cognitive Behavioral Intervention; Behavioral
Lead sponsor: Beth Israel Deaconess Medical Center; Other
Eligibility: 65 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

A Physical Therapy Program Targeting Lower Extremity Selective Motor Control in Children With Spastic Cerebral Palsy

Study of Verinurad in Heart Failure With Preserved Ejection Fraction

Cognitive Behavioral Therapy and Chronic Pain Self-Management Within the Context of Opioid Reduction: The EMPOWER Study

Reduction of Risk for Low Back Injury in Theater of Operations

Collaborative Care for Older Adults With Back Pain (COCOA)

SAFE at Home: A Service to Provide Social Engagement to Community-Dwelling Persons With Dementia

Exercise Training Intensity and Nitrate Supplementation in Post-Menopausal Females on Hormone Therapy

Ph 1b: Safety & Immunogenicity of Ad5 Based Oral Norovirus Vaccine

Study of MRM-3379 in Male Participants With Fragile X Syndrome (BLOOM)

Adaptive Symptom Care Using Fish-Based Nutritional Directives Post Breast Cancer

A Hybrid Effectiveness-implementation Trial of a High School-based Executive Function Treatment for Autistic Youth

Efficacy and Safety of XT-150 in Osteoarthritis of the Knee

A Phase III Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin on CKD Progression in Participants With CKD and High Blood Pressure.

Immune System Function Following Vaccination in HIV Infected Children Taking Anti-HIV Drugs

Effect of High-Intensity Gait Training Using a Treadmill on Locomotion Recovery in Traumatic Brain Injury Patients

The Baltimore Experience Corps Study

Biology, Identity & Opportunity Study

A Study to Learn About the Safety and Immune Activity of RSVpreF in Children 2 to <18 Years of Age

AI Activity Study in Patients With Elevated Blood Pressure

A Study of Remibrutinib Using MR Imaging in Relapsing or Progressive MS

Treatment of Supine Hypertension in Autonomic Failure

Study of INKmune in Patients With mCRPC (CaRe Prostate)

Avacopan in Crescentic Immunoglobulin A Nephropathy (IgAN)

Multi-Component Prehabilitation for Major Elective Surgery